UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

 

Filed by the Registrant ☒

 

Filed by a Party other than the Registrant ☐

 

Check the appropriate box:
  Preliminary Proxy Statement
  Confidential, For Use of the Commission Only (As permitted by Rule 14a-6(e)(2))
  Definitive Proxy Statement
  Definitive Additional Materials
  Soliciting Material under § 240.14a-12

 

ANAVEX LIFE SCIENCES CORP.

(Name of Registrant as Specified in its Charter)

 

(Name of Person(s) Filing Proxy Statement, if
other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

  No fee required.
  Fee paid previously with preliminary materials.
  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Grafico Azioni Anavex Life Sciences (NASDAQ:AVXL)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Anavex Life Sciences
Grafico Azioni Anavex Life Sciences (NASDAQ:AVXL)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Anavex Life Sciences